Crown Laboratories Commences Friendly Tender Offer for All Outstanding Common Shares of Revance Therapeutics at $3.10 per share
Press Releases
December 12, 2024

Crown Laboratories Commences Friendly Tender Offer for All Outstanding Common Shares of Revance Therapeutics at $3.10 per share

Board of Directors of Revance Recommend Stockholders Tender their Shares

bradford

The Bradford Era

More by this Author
Local & Social